Medium materiality5/10
Elevance Health price target raised to $485 from $460 at Guggenheim
Why it may matterVerify against the original reporting
Bullish analyst signal; treat the target as an opinion rather than a forecast.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim raised its ELV target by about 5.4% to $485, roughly 11.7% above the posted price of $434.13. This is a constructive analyst revision, not a guarantee of future performance.
- Guggenheim raised its ELV target to $485 from $460.
- The new target is about 11.7% above the posted price.
Key facts
- 01
Target: $485
- 02
Posted price: $434.13
- 03
Analyst firm: Guggenheim
- 04
Analyst: Jason Cassorla
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.